Indian State Expands Access to EECP® Therapy for Patients

Through a program known as Public Private Partnership (PPP), the government of the state of Tamil Nadu in India, in cooperation with VasoMeditech Ltd., Vasomedical’s authorized distributor in India, has launched the Non-Invasive Ischemic Burden Reduction Program (NIBP-P) to bring EECP® Therapy to patients seeking treatment for their coronary artery disease in the government medical college hospitals in the region.

This new program aims to tackle the growing epidemic of cardiovascular disease in India and help the government handle the increase in the number of patients seeking treatment in the public hospital sector. The project includes a continuing medical education program launched by VasoMeditech in collaboration with Madras Medical College on non-invasive options for patients with recurrent angina and heart failure emphasizing the clinical benefits and use of EECP Therapy.

EECP® treatment is currently available through this program at Rajiv Gandhi Government Medical College Hospital, Coimbatore Medical College Hospital, K.M. Cherian Heart Foundation, Chettinad Health City Hospital, Rohini Hospital Tanjavoure and K.G. Hospital in Coimbatore. In the coming year Vasomeditech is planning to initiate additional programs through the PPP in private and public hospitals across the country.